RE:RE:RE:RE:RE:RE:Q4 just in….100% agreed!!
Dr.Hamza is passionate about the growth of Cloudmd, however the growth of this business is built around a customer centric focus to genuinely assist people with a better health outcome, and that is admirable as both a doctor and a human being.
On the business side, I wholehearredly agree that owning the platform is essential in future growth whenever and wherever the business chooses to expand..
After the current acquisitions are closed Cloudmd will have approximately $35m cash o/h to fund any further acquisitions deemed necessary. When you combine the M&A focus with that of organic growth and cost synergies, 2021 is going to be an incredible year for Cloudmd. Already EHS reflects $5m organic growth this year and once Visionpros acquisition is completed, the organic growth available from this platform are mind boggling, never mind the cost synergies overall which will likely drive cost savings to over $1.0m.
EXCITING TIMES AND ONE EXCITING COMPANY!